-- Days : -- HRS : -- MIN : -- SEC

Register Now →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|January 13, 2025

Managed Care Partnerships and Continuity of Care

A panelist discusses how strategic managed care partnerships can streamline care transitions between treatment settings to ensure uninterrupted support and monitoring for patients with Lambert-Eaton myasthenic syndrome.

Episodes in this series

EP. 1 LEMS and SCLC: Unraveling the Neuromuscular-Cancer Connection

EP. 1 LEMS and SCLC: Unraveling the Neuromuscular-Cancer Connection

EP. 2 Strategies to Alleviate the Clinical and Economic Burden of LEMS

EP. 2 Strategies to Alleviate the Clinical and Economic Burden of LEMS

EP. 3 The Clinical and Economic Impact of LEMS in SCLC Care

EP. 3 The Clinical and Economic Impact of LEMS in SCLC Care

1 expert is featured in this series.

EP. 4 Using Technology for Early Detection of LEMS

1 expert is featured in this series.

EP. 5 Team- and System-Based Approaches to Managing LEMS and Ensuring Access

1 expert is featured in this series.

EP. 6 The Role of Patient Engagement Tools and Patient Advocacy Groups in LEMS Care

1 expert is featured in this series.

EP. 7 Managed Care Partnerships and Continuity of Care

Video content above is prompted by the following:

How can managed care partnerships enhance continuity of care for patients transitioning between different treatment settings?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Vitamin D3 | Image Credit: Adisak - stock.adobe.com

High-Dose Vitamin D3 Fails to Improve PFS in Phase 3 Metastatic CRC Trial

ByBrooke McCormick

August 6th 2026

Katherine Wilemon, CEO of the Family Heart Foundation

Almost No Public Awareness of Lp(a), Elevated CVD Risk in the US: Katherine Wilemon

ByPearl Steinzor,Katherine Wilemon

August 6th 2026

Eosinophilic esophagitis | Image Credit: syahrir - stock.adobe.com

Patients With MASLD Had More Than 2 Times Higher Odds of Eosinophilic Esophagitis Across Age Groups

ByBrooke McCormick

August 6th 2026

Experts featured in this series.

Translating PFS Data for Patients: How Community Oncologists Communicate Trial Outcomes in RRFL

ByRyan Haumschild, PharmD, MS, MBA, CPEL,Christina Poh, MD,Tara Graff DO, MS

August 6th 2026

Avoiding TNF Cycling: When to Switch Drug Classes in Rheumatoid Arthritis

ByJulia Buchfuhrer, DO

August 6th 2026

Trending on AJMC

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

Setting Treatment Goals in RA: Remission, Joint Damage, and Systemic Risk

Predicting GLP-1 Discontinuation From Pharmacy Claims

Avoiding TNF Cycling: When to Switch Drug Classes in Rheumatoid Arthritis

Patients With MASLD Had More Than 2 Times Higher Odds of Eosinophilic Esophagitis Across Age Groups